CLINICAL RESEARCH
Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function
Thomas H. Schindler, MD*,
Jerson Cardenas, MD*,
John O. Prior, MD, PhD*,
Alvaro D. Facta, MD*,
Michael C. Kreissl, MD*,
Xiao-Li Zhang, MD, PhD*,
James Sayre, PhD*,
Magnus Dahlbom, PhD*,
Julio Licinio, MD and
Heinrich R. Schelbert, MD, PhD*,*
* Department of Molecular and Medical Pharmacology
Department of Psychiatry and Biobehavioral Science and Medicine/Endocrinology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, California
Manuscript received August 6, 2005;
revised manuscript received September 30, 2005,
accepted October 10, 2005.
* Reprint requests and correspondence: Dr. Heinrich H. Schelbert, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, 23-120 CHS, Box 173517, Los Angeles, California 90095-1735 (Email: hschelbert{at}mednet.ucla.edu).
OBJECTIVES: We sought to evaluate effects of obesity, insulin resistance, and inflammation on coronary circulatory function and its relationship to leptin plasma levels.
BACKGROUND: It is not known whether obesity, commonly paralleled by insulin resistance, inflammation, and leptin, is independently associated with coronary circulatory dysfunction.
METHODS: Myocardial blood flow (MBF) responses to cold pressor test (CPT) and pharmacologic vasodilation was measured with positron emission tomography and 13N-ammonia. Study participants were divided into three groups based on their body mass index (BMI, kg/m2): control, 20  BMI <25 (n = 19); overweight, 25 BMI <30 (n = 21); and obese, BMI >30 (n = 32).
RESULTS: Body mass index was significantly correlated to the Homeostasis Model Assessment Index of insulin resistance and C-reactive protein levels (r = 0.60 and r = 0.47, p < 0.0001). Compared with control subjects, endothelium-related change in MBF ( MBF) to CPT progressively declined in overweight and obese groups (0.32 ± 0.09 vs. 0.21 ± 0.19 and 0.07 ± 0.16 ml/g/min; p < 0.03 and p < 0.0001). The dipyridamole-induced total vasodilator capacity was significantly lower in obese than in control subjects (1.77 ± 0.51 vs. 2.04 ± 0.37 ml/g/min, p < 0.02). On multivariate analysis, BMI (p < 0.012) and age (p < 0.035) were significant independent predictors of MBF. Finally, only in the obese group leptin plasma levels significantly correlated with MBF (r = 0.37, p < 0.036).
CONCLUSIONS: Increased body weight is independently associated with abnormal coronary circulatory function that progresses from an impairment in endothelium-related coronary vasomotion in overweight individuals to an impairment of the total vasodilator capacity in obese individuals. The findings that elevated leptin plasma levels in patients that are obese might exert beneficial effects on the coronary endothelium to counterbalance the adverse effects of increases in body weight on coronary circulatory function should be tested.
|
Abbreviations and Acronyms
| | ANOVA = analysis of variance | | BMI = body mass index | | CAD = coronary artery disease | | CPT = cold pressor test | | CRP = C-reactive protein | | CVR = coronary vascular resistance | | ECG = electrocardiogram | | HDL = high-density lipoprotein | | HOMA = Homeostasis Model Assessment | | LDL = low-density lipoprotein | | MBF = myocardial blood flow | | PET = positron emission tomography | | ROS = reactive oxygen species | | RPP = rate-pressure product | | WHR = waist-hip ratio |
|
This article has been cited by other articles:
|
|
|
|
 
P. A. Ades, P. D. Savage, S. Lischke, M. J. Toth, J. Harvey-Berino, J. Y. Bunn, M. Ludlow, and D. J. Schneider
The Effect of Weight Loss and Exercise Training on Flow-Mediated Dilatation in Coronary Heart Disease: A Randomized Trial
Chest,
December 1, 2011;
140(6):
1420 - 1427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Di Carli, D. Charytan, G. T. McMahon, P. Ganz, S. Dorbala, and H. R. Schelbert
Coronary Circulatory Function in Patients with the Metabolic Syndrome
J. Nucl. Med.,
September 1, 2011;
52(9):
1369 - 1377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Di Carli and V. L. Murthy
Cardiac PET/CT for the Evaluation of Known or Suspected Coronary Artery Disease
RadioGraphics,
September 1, 2011;
31(5):
1239 - 1254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hirata, M. Tabata, H. Kurobe, T. Motoki, M. Akaike, C. Nishio, M. Higashida, H. Mikasa, Y. Nakaya, S. Takanashi, et al.
Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose Tissue
J. Am. Coll. Cardiol.,
July 12, 2011;
58(3):
248 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Quercioli, Z. Pataky, G. Vincenti, V. Makoundou, V. Di Marzo, F. Montecucco, S. Carballo, A. Thomas, C. Staub, S. Steffens, et al.
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
Eur. Heart J.,
June 1, 2011;
32(11):
1369 - 1378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Schindler, H. R. Schelbert, A. Quercioli, and V. Dilsizian
Cardiac PET Imaging for the Detection and Monitoring of Coronary Artery Disease and Microvascular Health
J. Am. Coll. Cardiol. Img.,
June 1, 2010;
3(6):
623 - 640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Martell, B. Alvarez-Alvarez, and A. Fernandez-Cruz
Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines
Therapeutic Advances in Cardiovascular Disease,
April 1, 2010;
4(2):
97 - 103.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Borbouse, G. M. Dick, G. A. Payne, Z. C. Berwick, Z. P. Neeb, M. Alloosh, I. N. Bratz, M. Sturek, and J. D. Tune
Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation
Am J Physiol Heart Circ Physiol,
April 1, 2010;
298(4):
H1182 - H1189.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Borbouse, G. M. Dick, G. A. Payne, B. D. Payne, M. C. Svendsen, Z. P. Neeb, M. Alloosh, I. N. Bratz, M. Sturek, and J. D. Tune
Contribution of BKCa channels to local metabolic coronary vasodilation: effects of metabolic syndrome
Am J Physiol Heart Circ Physiol,
March 1, 2010;
298(3):
H966 - H973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Torre-Villalvazo, F. Gonzalez, C. A. Aguilar-Salinas, A. R. Tovar, and N. Torres
Dietary Soy Protein Reduces Cardiac Lipid Accumulation and the Ceramide Concentration in High-Fat Diet-Fed Rats and ob/ob Mice
J. Nutr.,
December 1, 2009;
139(12):
2237 - 2243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. R. Schelbert
Coronary Circulatory Function Abnormalities in Insulin Resistance: Insights From Positron Emission Tomography
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5_Suppl_S):
S3 - S8.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Hingorani, T. Shah, J. P. Casas, S. E. Humphries, and P. J. Talmud
C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?
Clin. Chem.,
February 1, 2009;
55(2):
239 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. I. Levy, E. L. Schiffrin, J.-J. Mourad, D. Agostini, E. Vicaut, M. E. Safar, and H. A.J. Struijker-Boudier
Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus
Circulation,
August 26, 2008;
118(9):
968 - 976.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Torre-Villalvazo, A. R. Tovar, V. E. Ramos-Barragan, M. A. Cerbon-Cervantes, and N. Torres
Soy Protein Ameliorates Metabolic Abnormalities in Liver and Adipose Tissue of Rats Fed a High Fat Diet
J. Nutr.,
March 1, 2008;
138(3):
462 - 468.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Exp Biol Med,
June 1, 2007;
232(6):
727 - 736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Johannsson, T. Henriksen, and P. O. Iversen
Increase in matrix metalloproteinases from endothelial cells exposed to umbilical cord plasma from high birth weight newborns
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2007;
292(4):
R1563 - R1568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T H Schindler, A D Facta, J O Prior, J Cadenas, W A Hsueh, M J Quinones, and H R Schelbert
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes
Heart,
March 1, 2007;
93(3):
345 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann
Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET
J. Nucl. Med.,
September 1, 2006;
47(9):
1420 - 1426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
